Kd) was present in nblnb and in + / + fetal reticulocytes.
Ank-2-related fetal liver mRNAs were present during the time the liver was actively generating erythrocytes. Neither the Ank-2-related transcripts nor the 1 55-Kd ANK-2-related protein were found in + / + or mutant adult reticulocytes. The data indicate that (1 ) unique ankyrin-related proteins and mRNAs present in fetal erythrocytes may stabilize the ankyrin-deficient nblnb erythrocytes and (2) adult nblnb mice may upregulate fetal gene transcripts to compensate for the ANK-1 deficiency. 0 1993 by The American Society o f Hematology.
been cloned and sequenced.20-22 Ank-1 codes for the major form of ankyrin found in erythrocytes and maps to chromosome 8 in both the and the mouse.'* Ank-2 encodes the major form found in the brain and maps to human chromosome 422 and to mouse chromosome 3.24 Recently, a third ankyrin gene (Ank-3) was identified in the mouse. It maps to murine chromosome 10 and is most highly expressed in the kidney, brain, and skin.25 Evidence suggests a fourth gene encodes the ankyrin detected at the nodes of Ranvier.* 6 The normoblastosis (nb) mutation maps to the Ank-1 locus on mouse chromosome 8'* and ANK-1 protein (210 Kd) and mRNA are markedly reduced in adult nblnb erythroid tissues.24 Mice homozygous for the mutation have severe hemolytic anemia." The nblnb reticulocytes have a dramatically shortened life span and the mice compensate by producing large numbers of splenic reticulocytes.28 The normoblastosis mutants are models of the heritable hemolytic anemia in humans known as hereditary spherocytosis-2 (gene symbol SPH-1).I4sZ3 Recently, we extended our studies of the nb mutation to include the fetus and neonate. Surprisingly, despite a deficiency of ANK-1 protein and mRNA as severe as that of adult nblnb mice, fetal nb/nb mice have normal RBC counts.z9 Other clinical symptoms associated with adult nb/ nb mutants (elevated reticulocyte count, tissue iron deposits, and RBC fragmentation) did not appear until just before or after birth. Notably, within the first 5 to 6 postnatal days, the clinical parameters in the nb/nb neonates deteriorated markedly.
In the present study, we examined developing fetal erythroid cells for evidence of ankyrin isoforms unique to the fetus as a first step in accounting for the lack of anemia in nb/nb mice prenatally. We demonstrate that fetal-specific ANK-1-and ANK-2-related proteins and mRNAs exist. In addition to their potential for ameliorating the effects of ANK-1 deficiency in nblnb fetuses, these novel ankyrins are candidates for mediating the spectrin assembly and disassembly that accompanies membrane remodelling during erythropoiesis in utero.
FETAL ANKYRIN PRODUCTS
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MATERIALS AND METHODS All mice were raised in our research colony at The Jackson Laboratory. The nb mutation was maintained on two inbred strains, WB/Re (WB) and C57BL/6J (B6). Homozygotes (WBB6FI-nblnb) were obtained by crossing WB and 86 proven +/nb heterozygotes?' Normal B6-+/+ and B6-+/+ mice with a phenylhydrazine (Sigma P7 126; Sigma, St Louis, MO)'-induced hemolytic anemia were used as controls.
For isolation of erythroid cells from normal fetuses, B6-+/+ breeding pairs were used. Females were observed daily for the presence of a vaginal plug indicating day 0 of pregnancy. All females allowed to go to term delivered during the night of day 18, ie, newborns were present on the morning of day 19. For production of nb/nb litters, two crosses were performed. First, WBB6FI-nblnb females and males were mated together, but difficulties were encountered because the WBB6FI-nblnh mice have reduced fertility. Second, WBB6FI-nbI nb ovaries were transplanted into ovariectomized WBB6FI-nb/+ female littermates and the recipients were mated to WBB6FI-nb/+ males." In this mating scheme, 50% of the offspring were expected to be nb/nb mice. Because nb/nb fetuses were phenotypically normal, they were identified by Northern blot analyses of fetal liver RNA to show absence or marked reduction ofAnk-1 expression as previously de~cribed?~.'~ Mutant nb/nb fetuses and newborns derived by the ovarian transplantation technique did not differ in any regard from those derived from WBB6FI-nb/nh breeding pairs. Hence, all data from the two groups of nb/nb mice were combined. The probe used to detect the erythroid Ank-1 transcripts was a 4.6-kb murine cDNA (mAnk-I) encoding Animals.
Isolation offetal
Hybridization probes. the 3' portion of the band 3 binding (89 Kd) domain and all of the @-spectrin binding and regulatory domains.3s Brain ankyrin (Ank-2) transcripts were detected with a 2.0-kb human brain ankyrin cDNA, hBrAnk-2, in which all but the 5'-most 24 bp encode the regulatory domain of the molecule?2 The regulatory domain is the most divergent region among the ankyrins cloned to date. The probes were 32P-labeled by the random hexamer method of Feinberg and VogelsteinM to a specific activity of no less than 1 X IO9 cpm/pg cDNA.
Northern blots. Total cellular RNA from adult spleen, reticulocytes, PBS-perfused liver, and from fetal erythroid cells was prepared by the acid guanidinium-thiocyanate-phenol-chloroform method." Polyadenylated (PA+) RNA was isolated by oligo(dT)-cellulose ~hromatography.~' Samples were fractionated in agarose-formaldehyde gels, transferred to nylon filters,39 and hybridized (2 to 3 X IO6 cpm probe/mL hybridization mixture) under conditions specified for Zetabind filters (AMF CUNO, Meriden, CT) with 1% SDS. After hybridization, filters probed with mAnk-I were rinsed in 2X SSC, 0. I% SDS at room temperature for I5 minutes, and then two times for 30 minutes each in 0.IX SSC, 0.1% SDS at either 42OC (low stringency wash) or 65OC (high stringency wash). Filters probed with hBrAnk-2 were washed at 55°C. Filters were exposed to Kodak XAR-5 film (Eastman Kodak, Rochester, NY) at -70°C with an intensifying screen.
RESULTS
ANK-I-related proteins and mRNA in fetal hematopoietic cells. When normal adult reticulocyte ghost proteins are probed on Western blots using ANK-I-specific antibodies, a 210-Kd (full length) ankyrin and several smaller ANK-Irelated proteins are detected." The same experiment, when performed on adult nb/nb ghost proteins, shows little, if any, full-length ankyrin, but does consistently demonstrate an ANK-I-related protein that appears to be unique to the nb allele ( Fig I , lane 2) . We have reported these results previously's and estimated the protein associated with nblnb to be 150 Kd on the original gels. In the present report, the mutant associated protein on the current gels measures 165 Kd and will be referred to as such throughout this report. (Fig 2) . Indeed, the level of the 5.5-kb Ank-1 mRNA is consistently higher in nb/nb adults versus +/+ adults. The difficulty of detecting the 5.5-kb transcript with the mAnk-I probe under high stringency conditions raises the possibility that the 5.5-kb transcript is the product of a gene related to but distinct from Ank-I.
ANK-2-related proteins and mRNAs inseta1 hematopoietic cells. By immunoblot analysis, using an affinity-purified antibody raised against the regulatory domain of human brain ankyrin (ANK-2), a 155-Kd protein is detected in +/+ and nb/nb 16-day fetal but not adult reticulocyte ghost proteins (Fig 3a) . This protein migrates to a position distinct from the ANK-I-related (165 Kd) protein when side by side lanes from the same electrophoretic gel are exposed to either ANK-I or ANK-2 antibodies (data not shown). The 155-Kd ANK-2 protein is specific for early fetal reticulocytes because it is not detected beyond fetal day I8 in normal animals (Fig 3b) . While the 155-Kd ANK-2 may help compensate for structural problems in the nb/nb fetal cells, it does not persist and, therefore, does not play a similar role in adult nblnb reticulocytes. The 155-Kd ANK-2 is more likely a part of the normal fetal erythroid developmental pathway. Although immunologic reactivity cannot conclusively identify the proteins, the results indicate that the 155-Kd protein is more closely related to ANK-2 than to ANK-I and, conversely, that the 165-Kd protein is more closely related to ANK-I than to ANK-2. a polyclonal antihuman erythroid ankyrin IgG (Fig I) . The 165-Kd fetal +/+ protein comigrates with the adult mutant ANK-1. The protein persists from at least fetal day I6 into adulthood in nb/nb mice. The 165-Kd ANK-I appears to be a developmentally regulated ankyrin in +/+ mice because we failed to demonstrate its presence in reticulocytes beyond I7 days of gestation (data not shown). The persistence of the 165-Kd ANK-I in nb/nb mice suggests the intriguing possibility that the erythroid ankyrin previously shown to be associated with the nb mutation represents a normal fetal protein rather than a product of the mutant gene.
An mRNA of the appropriate size to encode the 165-Kd protein was found. Previously, we reported the presence of two major Ank-1 transcripts (9.0 and 7.5 kb) in normal erythroid tissues and showed that both transcripts were markedly reduced in nb/nb tissues.24 We examined Ank-I expression in fetal tissue and again in adult tissue using the same cDNA probe (mAnk-I) but labeled to at least a IO-fold higher specific activity (21 X IO9 current v 1 X lo8 previously). In addition, we increased the amount of labeled probe in the hybridization mixture to 3 X IO6 cpm/mL (versus 2 X IO6) and used both low (42OC) and high (65°C) stringency wash temperatures. A previously undetected Ank-1 message of 5.5 kb is detected with the high as well as with the low stringency washes. Unlike the 9.0-and 7.5-kb mRNA, the level of expression of the 5.5-kb Ank-1 transcript is not affected by the nb mutation For personal use only. on October 23, 2017. by guest www.bloodjournal.org From Unexpectedly, we found that the ANK-2 antibody crossreacts with proteins in +/+ but not in nb/nb fetal and adult reticulocytes (including a 2 IO-Kd protein). The lack of specific ANK-2-reactive products in the ANK-I-deficient reticulocyte ghosts (Fig 3a) suggests that the ANK-2 antibody recognizes some, although not all, ANK-I epitopes. Supporting evidence is the fact that no ANK-2 transcripts have been detected in normal adult reticulocyte^.^^ Previously, we described brain ankyrin (Ank-2) transcripts in adult brain but not in the reticulocytes of +/+ and nb/nb mice (Fig 4, lanes 1 and 2) . This confirmed that Ank-2. encoded by a gene on chromosome 3, is unaffected by the nb mutation. In the present report, using the Ank-2 regulatory domain cDNA as a probe, no Ank-2 transcripts are detected in 16day +/+ or nb/nb fetal reticulocytes (Fig 4, lanes 4 through 6). Furthermore, no Ank-2 transcripts are found in normal or nblnb adult liver or phenylhydrazine-treated +/ + spleen RNA (data not shown). Ank-2 transcripts of IO, 8, 5 , and 3.0 kb are detected with this probe in normal and nb/ nb 16day fetal liver (Fig 4, lanes 7 and 8) . Thus, Ank-2 expression outside the nervous system appears to be limited to the fetal liver. The IO-, 8-, and 5-kb transcripts are possible candidate mRNAs for the 155-Kd ANK-2 protein in I6day fetal reticulocytes because the fetal liver is the site of erythroid cell p r o d u~t i o n .~~.~~ The overall pattern Ank-2 mRNAs detected in fetal liver are distinct from those in the adult brain." Whether the fetal liver transcripts are alternatively spliced products of the Ank-2 gene or of a closely related gene cannot be ascertained with any degree of certainty at this time.
DISCUSSION
In this study, we demonstrate that unique ankynn-related proteins and mRNAs exist in fetal erythroid tissues and reticulocytes (Table I) . We postulate that these ankyrins and/ or mRNAs function during erythropoiesis in utero and ameliorate the effects of ANK-I deficiency in nb/nb mice in utero. Two distinct fetal ankyrin-related proteins are detected by Western blotting of fetal reticulocyte ghost proteins. The first, an ANK-I-related protein of 165 Kd, comigrates with an ANK-1 immunoreactive species previously described in ankyrindeficient nblnb adults and called p I50.'* Our current studies suggest that the 165-Kd ANK-I-related protein (formerly p 150) is a fetal product that persists in adult mutant but not +/+ reticulocyte ghosts. Its continued production in A previously undetected 5.5-kb mRNA was noted by Northern blot analysis using a murine Ank-I cDNA probe. This Ank-I message, approximately 5.5 kb, is of the appropriate size but its expression pattern is not entirely consistent (Fig 2 and Table I ) with the encoding of a 165-Kd protein.
The 5.5-kb mRNA is present in +/+ reticulocytes at 18 days ofgestation and at birth when the 165-Kd protein is missing. It could be argued that there is differential translation of the 5.5-kb mRNA or that the 165-Kd ANK-I is unstable. Alternatively, it may simply be that the sensitivity of mRNA detection by Northern analysis exceeds the sensitivity of protein detection using the antibodies available. In any case, the 5.5-kb Ank-I mRNA is, similar to the 165-Kd ANK-I protein, downregulated in normal mice postnatally but is still present in nb/nb adults. Unlike the 9.0-and 7.5-kb Ank-I transcripts, the 5.5-kb message is unaffected by the nb mutation, raising the possibility that it is the product of a related but distinct gene. At present, there is insufficient data to exclude the possibility that the 5.5-kb mRNA is an alternatively spliced Ank-I product that does not involve the defect in the Ank-I gene of nb/nb mice. 16-and 17-day fetuses. The fact that the 155 Kd ankyrin is not detected in either normal or mutant l 8-day fetuses, neonates, and adults is consistent with the limited Ank-2 expression. Fetal reticulocytes at 16 and 17 days of gestation are derived from erythroid precursors of the fetal liver.42 Subsequently, the fetal liver is no longer a significant erythropoietic organ.
Indeed, we noted a marked diminution of both Ank-1 and Ank-2 transcripts to barely detectable levels in the 18-day fetal liver (data not shown).
It is interesting that the Ank-2 transcripts detected in 16-day fetal liver differ from those detected in the brain. At present, there is insufficient data to determine whether these Ank-2-related messages are alternatively spliced transcripts of the murine Ank-2 gene or products of a distinct but closely related gene.
Tissue-and stage-specific mRNA processing of erythroid ankynn (Ank-1),2°,24332 brain ankyrin (Ar~k-2);~ protein 4.1 , 4447 and erythroid p spectrin4* have been described. In the case of ankyrin, protein isoforms derived from alternative splicing of the erythroid transcript have different binding capacities; deletion of a single exon within the regulatory domain of the molecule converts ankyrin 2.1 into "activated" ankyrin 2.2 that displays increased affinity for both spectrin and band 3.49 Morever, unique mRNA spliceoforms of the other major cytoskeletal linker protein, band 4.1, are known that create isoforms within the functionally critical spectrin-binding doHence, tissue-specific and developmentally regulated alternatively spliced mRNAs represent a potential major source of functional diversity. In this study, we have identified unique ankyrin-related proteins and mRNAs in fetal reticulocytes. These ankyrin proteins and mRNAs are potential candidates to meet the diverse demands of erythrocyte membrane remodelling in utero. The onset of hemolytic anemia in nb/nb mice coincident with the normal decline of these fetal products provides evidence that they are functionally important. Studies are in progress to define the functional capabilities of the 165-Kd ANK-I-related and the 155-Kd ANK-2-related fetal proteins and to search for Ank-1 and Ank-2 cDNAs in nb/nb mice to determine their homology (or lack of) to the known Ank-I and Ank-2 genes.
